Artificial intelligence helps doctors spot more cases of breast cancer when reading routine scans, a world-first trial found ...

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, particularly in regions with ...

I am delighted that oncologists finally have a way to identify HR+/HER2- early breast cancer patients who will benefit from anthracycline therapy," said Joyce A. O’Shaughnessy, M.D., principal ...

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, particularly in regions with ...

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU ® (trastuzumab deruxtecan) in combination with pertuzumab for the first-line ...

A scientist in the French city of Orleans holds up a test tube containing messenger RNA While mRNA was discovered in the early 1960s, it rose to global prominence when it was used in some Covid ...

Juana Fernandez shows her scar from breast cancer surgery at the Amama office in Seville Oncology patients Charo Castro (L), Anabel Cano (2L) and Amparo Perez (R) pose with Amama breast cancer ...

Hepatocellular carcinoma (HCC) is the most common subtype of primary liver cancer and continues to be a major cause of cancer ...

From combining treatments in unprecedented ways to deploying artificial intelligence for personalised medicine, a raft of new advances in the fight against cancer have been presented at the European ...